EP4729522A1 — Crystal forms of sodium salt of polycyclic carbamoylpyridone derivative, and preparation method therefor and use thereof
Assigned to Jiangsu Aidea Pharmaceutical Group Co Ltd · Expires 2026-04-22 · 0y expired
What this patent protects
Provided in the present invention are crystal forms of the sodium salt of an HIV-1 integrase inhibitor molecule. Specifically, provided in the invention are crystal form A and crystal form B of the sodium salt of a compound as shown in formula 1. The crystal forms of the present …
USPTO Abstract
Provided in the present invention are crystal forms of the sodium salt of an HIV-1 integrase inhibitor molecule. Specifically, provided in the invention are crystal form A and crystal form B of the sodium salt of a compound as shown in formula 1. The crystal forms of the present invention can be used for preventing and/or treating diseases related to HIV infections and selectively inhibiting the activity of HIV integrase.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.